eISSN: 2084-9834
ISSN: 0034-6233
Reumatologia/Rheumatology
Current issue Archive About the journal Supplements Editorial board Abstracting and indexing Subscription Contact Instructions for authors Ethical standards and procedures
SCImago Journal & Country Rank
 
6/2005
vol. 43
 
Share:
Share:
more
 
 
abstract:

ARTYKUŁ PRZEGLĄDOWY/REVIEW PAPER
Cardiovascular system involvement in systemic lupus erythematosus – review and own observations. Serological risk factor of cardiological complications

Lidia Ostanek
,
Edyta Płońska
,
Marek Brzosko
,
Krzysztof Mokrzycki
,
Małgorzata Peregud-Pogorzelska
,
Katarzyna Fischer

Ru 2005; 43, 6: 373-378
Online publish date: 2005/12/22
View full text
Get citation
ENW
EndNote
BIB
JabRef, Mendeley
RIS
Papers, Reference Manager, RefWorks, Zotero
AMA
APA
Chicago
Harvard
MLA
Vancouver
 
Systemic lupus erythematosus is an autoimmune disease, in the course of which involvement of the circulatory system is one of the common systemic manifestations, very important from the prognostic point of view. Involvement the heart affects most commonly pericardium and valvular system; myocardium is affected rarely. Patients with SLE have a high risk of early atherosclerosis in the form of coronary disease and myocardial infarct. Unlike in the general population, risk factors of cardiovascular complications in the SLE patients are mainly antiphospholipid antibodies, duration of the disease, duration of glucocorticoid therapy, as well as lipid disorders, anti-oxLDL antibodies, and high levels of CRP, a1-antitripsin and homocystein. Own observations on cardiac manifestation in the SLE patients and serological risk factors related to cardiac involvement are discussed in the paper.
keywords:

systemic lupus erythematosus; heart abnormalities, serological risk factor, antiphospholipid antibodies



Quick links
© 2020 Termedia Sp. z o.o. All rights reserved.
Developed by Bentus.
PayU - płatności internetowe